They must also review the risk assessment if the results of any monitoring show it to be necessary, or if the blood-lead concentration of any employee under medical surveillance reaches the action level. Under Regulation 6, employers must prevent exposure to lead by substituting a substance or process that eliminates or reduces the risk to employees.